[The apolipoprotein E gene and Alzheimer disease phenotype]

Area of Science:

• Neurogenetics
• Cardiovascular Genetics
• Epidemiology

Context:

• Alzheimer's disease (AD) is a progressive neurodegenerative disorder.
• The apolipoprotein E (APOE) gene, particularly the epsilon 4 (ε4) allele, is a significant genetic risk factor for late-onset AD.
• The interaction between APOE ε4, age, and AD onset requires further elucidation.

Purpose:

• To investigate the independence of the apolipoprotein E epsilon 4 allele's risk for Alzheimer's disease concerning age.
• To examine the association between APOE genotype and age of symptom onset in AD patients.
• To explore potential confounding factors, such as coronary heart disease risk, in the observed associations.

Summary:

• This study analyzed 126 AD patients and 72 controls (ages 44-95) to assess the APOE ε4 allele's role in AD risk and onset.
• The APOE ε4 allele's association with AD risk was found to be independent of age across the studied population.
• An earlier symptom onset in ε4 carriers was observed only in the oldest patients, potentially influenced by competing risks like coronary heart disease.

Impact:

• Findings clarify the age-independent genetic risk conferred by APOE ε4 in Alzheimer's disease.
• Highlights the potential for selection bias in studies examining early-onset AD and APOE ε4.
• Suggests that the interplay of genetic predisposition and age-dependent comorbidities influences clinical presentation in Alzheimer's disease.